This means that even though TCGA data shows that NETO2, CDK6, OLR1, and TGFBI are underexpressed in HNSCC tissue compared to normal adjacent one, patients who show a low expression of this gene have a better disease outcome with regard to overall survival rate. Here, TGFBI is linked to head and neck squamous cell carcinoma.